Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 26.00
-0.45 (-1.70%)
At close: Jul 8, 2026
Mycenax Biotech Market Cap
Mycenax Biotech has a market cap or net worth of 5.32 billion as of July 9, 2026. Its market cap has decreased by -34.39% in one year.
Market Cap
5.32B
Enterprise Value
6.28B
Revenue
815.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.00
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 5.32B, an increase of 810.03%. That is a compound annual growth rate of 13.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.32B | -18.82% |
| Dec 31, 2025 | 6.55B | -26.98% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.57B |
| Savior Lifetec | 6.58B |
| TaiGen Biopharmaceuticals Holdings | 6.55B |
| Sinphar Pharmaceutical | 6.43B |
| AnnJi Pharmaceutical | 6.23B |
| TWi Biotechnology | 5.48B |
| UnicoCell Biomed | 5.18B |
| Medigen Biotechnology | 5.16B |